Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
Launched by UNIVERSITY OF MINNESOTA · Sep 13, 2005
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age =\>18
- • \<8mm ureteral calculus below the pelvic brim identified by non-contrast CT scan and/or intravenous pyelogram
- Exclusion Criteria:
- • Subject with know hypersensitivity to Alfuzosin hydrochloride or any component of Alfuzosin hydrochloride tablets
- • Pregnant/Nursing females
- • Solitary kidney
- • Renal insufficiency (Creatinine\>1.8)
- • Urinary infection (fever \>101, positive urine culture, many bacteria on urinalysis)
- • Moderate or severe hepatic insufficiency (Childs-Pugh categories B and C)
- • Potent CYP3A4 inhibitors such as ketoconazole, itraconazole, and ritonavir, since Alfuzosin blood levels are increased
- • Other alpha-blockers
- • Phosphodiesterase type 5 inhibitors for erectile dysfunction
- • Any subject for whom the principal investigator feels it would not be in his or her best interest to participate in the study
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Manoj Monga, MD
Principal Investigator
University of Minnesota and VAMC Minneapolis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials